An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases

Jerome Robert*, Nicholas L. Weilinger, Li Ping Cao, Stefano Cataldi, Emily B. Button, Sophie Stukas, Emma M. Martin, Philip Seibler, Megan Gilmour, Tara M. Caffrey, Elyn M. Rowe, Jianjia Fan, Brian MacVicar, Matthew Farrer, Cheryl L. Wellington

*Corresponding author for this work
14 Citations (Scopus)

Abstract

Introduction: The neurovascular unit (NVU) – the interaction between the neurons and the cerebrovasculature – is increasingly important to interrogate through human-based experimental models. Although advanced models of cerebral capillaries have been developed in the last decade, there is currently no in vitro 3-dimensional (3D) perfusible model of the human cortical arterial NVU. Method: We used a tissue-engineering technique to develop a scaffold-directed, perfusible, 3D human NVU that is cultured in native-like flow conditions that mimics the anatomy and physiology of cortical penetrating arteries. Results: This system, composed of primary human vascular cells (endothelial cells, smooth muscle cells and astrocytes) and induced pluripotent stem cell (iPSC) derived neurons, demonstrates a physiological multilayer organization of the involved cell types. It reproduces key characteristics of cortical neurons and astrocytes and enables formation of a selective and functional endothelial barrier. We provide proof-of-principle data showing that this in vitro human arterial NVU may be suitable to study neurovascular components of neurodegenerative diseases such as Alzheimer’s disease (AD), as endogenously produced phosphorylated tau and beta-amyloid accumulate in the model over time. Finally, neuronal and glial fluid biomarkers relevant to neurodegenerative diseases are measurable in our arterial NVU model. Conclusion: This model is a suitable research tool to investigate arterial NVU functions in healthy and disease states. Further, the design of the platform allows culture under native-like flow conditions for extended periods of time and yields sufficient tissue and media for downstream immunohistochemistry and biochemistry analyses.

Original languageEnglish
Article number70
JournalMolecular Neurodegeneration
Volume15
Issue number1
DOIs
Publication statusPublished - 12.2020

Funding

This work was supported by Weston Brain Institute Rapid Response grants (RR182093 & RR150048), and a BrightFocus Foundation Alzheimer?s Disease Award awarded to JR. A Cure Alzheimer Fund, NSERC discovery, and Canadian Consortium of Neurodegeneration and Aging (CCNA) grants awarded to CLW. JR was further supported by Michael Smith Foundation for Health Research (MSFHR)/CCNA and UBC Faculty of Medicine Bluma Tischler fellowships. EBB was supported by a UBC Four Year Doctoral Fellowship and a Canadian Institutes of Health Research Doctoral Fellowships. EMR was supported by an Alzheimer Society of Canada Doctoral Award and a University of British Columbia Faculty of Medicine Graduate Award. NLW was supported by postdoctoral fellowships from MSFHR and the Canadian Institutes for Health Research (CIHR, Banting Award). BAM holds grants from CIHR (#FDN148397) and Fondation Leducq (15CVD02). PS was supported by a postdoctoral fellowship from the German Research Foundation (SE 2608/1-1). SC and L-PZ were supported through a Canadian Excellence Research Chair to MJF. This work was supported by Weston Brain Institute Rapid Response grants (RR182093 & RR150048), and a BrightFocus Foundation Alzheimer’s Disease Award awarded to JR. A Cure Alzheimer Fund, NSERC discovery, and Canadian Consortium of Neurodegeneration and Aging (CCNA) grants awarded to CLW. JR was further supported by Michael Smith Foundation for Health Research (MSFHR)/CCNA and UBC Faculty of Medicine Bluma Tischler fellowships. EBB was supported by a UBC Four Year Doctoral Fellowship and a Canadian Institutes of Health Research Doctoral Fellowships. EMR was supported by an Alzheimer Society of Canada Doctoral Award and a University of British Columbia Faculty of Medicine Graduate Award. NLW was supported by postdoctoral fellowships from MSFHR and the Canadian Institutes for Health Research (CIHR, Banting Award). BAM holds grants from CIHR (#FDN148397) and Fondation Leducq (15CVD02). PS was supported by a postdoctoral fellowship from the German Research Foundation (SE 2608/1-1). SC and L-PZ were supported through a Canadian Excellence Research Chair to MJF.

Fingerprint

Dive into the research topics of 'An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this